title: [Case of primary malignant lymphoma of the bladder].
abstract: We report a case of primary malignant lymphoma of the bladder. An 87-year-old female visited our hospital for incidental bladder tumor. Cystoscopic examination demonstrated a non-papillary tumor over 10 mm in diameter. We performed transurethral resection of the bladder tumor. Histological examination showed malignant lymphoma, diffuse large B cell type. After further examination, it was diagnosed as primary malignant lymphoma of the bladder, stage IA E(Ann Arbor classification). We performed six courses of R-CHOP regimen (rituximab, cyclophosphamide, vincristine, doxorubicin, predonisolone). We did not find any local or distant recurrences after eight months' follow up.
authors.affiliation: The Department of Urology, Matsusaka Central General Hospital.
authors.forename: Daisuke
authors.initials: D
authors.lastname: Goto
authors.forename: Takeshi
authors.initials: T
authors.lastname: Otani
authors.forename: Atsushi
authors.initials: A
authors.lastname: Tomioka
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Maruyama
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D015653:Cystectomy; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D011241:Prednisone / Q000008:administration & dosage; D000069283:Rituximab; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; C571759:R-CHOP protocol; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone